Catalyst Wire Dossier Catalyst Wire Dossier

EGFR-TKIs (various)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFR-TKIs (various), covering 2016-09-01 to 2016-09-01. Get the full timeline:

Most recent: Clinical Trial Update: EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC [Phase 3]

See pricing